4-methoxyhonokiol has been researched along with nicotine in 1 studies
Studies (4-methoxyhonokiol) | Trials (4-methoxyhonokiol) | Recent Studies (post-2010) (4-methoxyhonokiol) | Studies (nicotine) | Trials (nicotine) | Recent Studies (post-2010) (nicotine) |
---|---|---|---|---|---|
49 | 0 | 37 | 28,519 | 2,280 | 9,302 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baek, IJ; Hong, JT; Jeong, J; Lee, BJ; Lee, JK; Lin, C; Nam, SY; Yon, JM; Yun, YW | 1 |
1 other study(ies) available for 4-methoxyhonokiol and nicotine
Article | Year |
---|---|
4-O-methylhonokiol inhibits serious embryo anomalies caused by nicotine via modulations of oxidative stress, apoptosis, and inflammation.
Topics: Animals; Apoptosis; Biphenyl Compounds; Caspase 3; Embryo Culture Techniques; Female; Glutathione Peroxidase; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Interleukin-1beta; Lignans; Lipid Peroxidation; Lymphoma, B-Cell; Male; Mice; Mice, Inbred ICR; Nicotine; Organogenesis; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase; Pregnancy; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2014 |